Vanguard Group’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $831M | Sell |
|
|||||
|
2025
Q2 | $568M | Buy |
|
|||||
|
2025
Q1 | $560M | Sell |
|
|||||
|
2024
Q4 | $526M | Sell |
|
|||||
|
2024
Q3 | $389M | Buy |
|
|||||
|
2024
Q2 | $506M | Buy |
|
|||||
|
2024
Q1 | $446M | Buy |
|
|||||
|
2023
Q4 | $364M | Buy |
|
|||||
|
2023
Q3 | $230M | Buy |
|
|||||
|
2023
Q2 | $339M | Buy |
|
|||||
|
2023
Q1 | $344M | Buy |
|
|||||
|
2022
Q4 | $368M | Buy |
|
|||||
|
2022
Q3 | $81.5M | Buy |
|
|||||
|
2022
Q2 | $88.2M | Buy |
|
|||||
|
2022
Q1 | $119M | Buy |
|
|||||
|
2021
Q4 | $95.2M | Buy |
|
|||||
|
2021
Q3 | $85.5M | Buy |
|
|||||
|
2021
Q2 | $102M | Buy |
|
|||||
|
2021
Q1 | $117M | Buy |
|
|||||
|
2020
Q4 | $98.8M | Buy |
|
|||||
|
2020
Q3 | $91M | Sell |
|
|||||
|
2020
Q2 | $92.6M | Sell |
|
|||||
|
2020
Q1 | $55.7M | Buy |
|
|||||
|
2019
Q4 | $71.6M | Sell |
|
|||||
|
2019
Q3 | $68.1M | Buy |
|
|||||
|
2019
Q2 | $78.7M | Sell |
|
|||||
|
2019
Q1 | $97.9M | Buy |
|
|||||
|
2018
Q4 | $84.2M | Buy |
|
|||||
|
2018
Q3 | $151M | Buy |
|
|||||
|
2018
Q2 | $129M | Buy |
|
|||||
|
2018
Q1 | $33.5M | Buy |
|
|||||
|
2017
Q4 | $25.2M | Buy |
|
|||||
|
2017
Q3 | $6.45M | Buy |
|
|||||
|
2017
Q2 | $1.29M | Sell |
|
|||||
|
2017
Q1 | $1.37M | Sell |
|
|||||
|
2016
Q4 | $1.32M | Sell |
|
|||||
|
2016
Q3 | $1.29M | Sell |
|
|||||
|
2016
Q2 | $1M | Sell |
|
|||||
|
2016
Q1 | $986K | Sell |
|
|||||
|
2015
Q4 | $1.51M | Buy |
|
|||||
|
2015
Q3 | $5.92M | Buy |
|
|||||
|
2015
Q2 | $6.8M | Buy |
|
|||||
|
2015
Q1 | $5.46M | Buy |
|
|||||
|
2014
Q4 | $5.58M | Buy |
|
|||||
|
2014
Q3 | $5.22M | Buy |
|
|||||
|
2014
Q2 | $6.31M | Sell |
|
|||||
|
2014
Q1 | $6.68M | Buy |
|
|||||
|
2013
Q4 | $7.49M | Buy |
|
|||||
|
2013
Q3 | $6.88M | Buy |
|
|||||
|
2013
Q2 | $5.25M | Buy |
|